NEW YORK (GenomeWeb News) – CardioDx today announced a deal with Core Diagnostics India for the marketing and sale of CardioDx's coronary artery disease test in India.

Under the terms of the deal, Core will make CardioDx's Corus CAD diagnostic test available to patients in India, which CardioDx said has one of the highest rates of CAD in the world. Blood samples collected for the test will be sent to the Palo Alto, Calif.-based firm's CLIA laboratory for analysis and turnaround.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.